Articles tagged with "anifrolumab"

What’s New in SLE: Pathogenesis & Novel Therapies

September 8, 2022 • By Samantha C. Shapiro, MD

New HCPCS Code Added for Anifrolumab-fnia, 1 mg

May 6, 2022 • By From the College

Anifrolumab Promising for Sustained Low Disease Activity in Patients with Lupus

May 5, 2022 • By Michele B. Kaufman, PharmD, BCGP

A Year to Remember: Dr. Jinoos Yazdany Presents the 2020 Clinical Research Review

December 7, 2020 • By Jason Liebowitz, MD

In Wake of Lupus Trial Failure, New Research Attacks From Many Angles

July 18, 2019 • By Thomas R. Collins

The Type I Interferon Pathway’s Influence in Connective Tissue Disease

July 18, 2019 • By Ruth Jessen Hickman, MD

Insight into Clinical Trials for Lupus

June 12, 2019 • By Thomas R. Collins

AstraZeneca Lupus Drug Fails to Meet Main Goal in Study

August 31, 2018 • By Reuters Staff

Effectiveness of Novel Therapies for Cutaneous SLE Explored

April 20, 2017 • By Thomas R. Collins

New SLE Drug May Allow Patients to Reduce Steroid Use

December 16, 2015 • By Michele B. Kaufman, PharmD, BCGP